158 related articles for article (PubMed ID: 30544459)
1. A new scoring model predicting macroscopic vascular invasion of early-intermediate hepatocellular carcinoma.
Liu Y; Sun L; Gao F; Yang X; Li Y; Zhang Q; Zhu B; Niu S; Huang Y; Hu Y; Feng Y; Jiang Y; Wang X
Medicine (Baltimore); 2018 Dec; 97(49):e13536. PubMed ID: 30544459
[TBL] [Abstract][Full Text] [Related]
2. Factors predicting long-term outcomes of early-stage hepatocellular carcinoma after primary curative treatment: the role of surgical or nonsurgical methods.
Kuo MJ; Mo LR; Chen CL
BMC Cancer; 2021 Mar; 21(1):250. PubMed ID: 33685409
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a novel predictive scoring model for microvascular invasion in patients with hepatocellular carcinoma.
Zhao H; Hua Y; Dai T; He J; Tang M; Fu X; Mao L; Jin H; Qiu Y
Eur J Radiol; 2017 Mar; 88():32-40. PubMed ID: 28189206
[TBL] [Abstract][Full Text] [Related]
4. Comparison of overall survival on surgical resection versus transarterial chemoembolization with or without radiofrequency ablation in intermediate stage hepatocellular carcinoma: a propensity score matching analysis.
Lin CW; Chen YS; Lo GH; Hsu YC; Hsu CC; Wu TC; Yeh JH; Hsiao P; Hsieh PM; Lin HY; Shu CW; Hung CM
BMC Gastroenterol; 2020 Apr; 20(1):99. PubMed ID: 32272898
[TBL] [Abstract][Full Text] [Related]
5. Validation of the SNACOR clinical scoring system after transarterial chemoembolisation in patients with hepatocellular carcinoma.
Mähringer-Kunz A; Weinmann A; Schmidtmann I; Koch S; Schotten S; Pinto Dos Santos D; Pitton MB; Dueber C; Galle PR; Kloeckner R
BMC Cancer; 2018 Apr; 18(1):489. PubMed ID: 29703174
[TBL] [Abstract][Full Text] [Related]
6. Vascular Invasion and Metastasis is Predictive of Outcome in Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma.
Mokdad AA; Singal AG; Marrero JA; Zhu H; Yopp AC
J Natl Compr Canc Netw; 2017 Feb; 15(2):197-204. PubMed ID: 28188189
[No Abstract] [Full Text] [Related]
7. Modified cisplatin-based transcatheter arterial chemoembolization for large hepatocellular carcinoma: multivariate analysis of predictive factors for tumor response and survival in a 163-patient cohort.
Yoon HM; Kim JH; Kim EJ; Gwon DI; Ko GY; Ko HK
J Vasc Interv Radiol; 2013 Nov; 24(11):1639-46. PubMed ID: 23962438
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
[TBL] [Abstract][Full Text] [Related]
9. Establishment of a predictive model for short-term efficacy of transcatheter arterial chemoembolization treatment in hepatocellular carcinoma and its clinical application.
Wei J; Wang Z
J Cancer Res Ther; 2019; 15(4):941-946. PubMed ID: 31436256
[TBL] [Abstract][Full Text] [Related]
10. Combined transarterial chemoembolization and radiotherapy as a first-line treatment for hepatocellular carcinoma with macroscopic vascular invasion: Necessity to subclassify Barcelona Clinic Liver Cancer stage C.
Kim YJ; Jung J; Joo JH; Kim SY; Kim JH; Lim YS; Lee HC; Kim JH; Yoon SM
Radiother Oncol; 2019 Dec; 141():95-100. PubMed ID: 31506181
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a prognostic model for patients with hepatocellular carcinoma undergoing radiofrequency ablation.
Kim CG; Lee HW; Choi HJ; Lee JI; Lee HW; Kim SU; Park JY; Kim DY; Ahn SH; Han KH; Kim HS; Kim KH; Choi SJ; Kim Y; Lee KS; Kim GM; Kim MD; Won JY; Lee DY; Kim BK
Cancer Med; 2019 Sep; 8(11):5023-5032. PubMed ID: 31290618
[TBL] [Abstract][Full Text] [Related]
12. Validation of the six-and-twelve criteria among patients with hepatocellular carcinoma and performance score 1 receiving transarterial chemoembolization.
Wang ZX; Li J; Wang EX; Xia DD; Bai W; Wang QH; Yuan J; Li XM; Niu J; Yin ZX; Xia JL; Fan DM; Han GH
World J Gastroenterol; 2020 Apr; 26(15):1805-1819. PubMed ID: 32351295
[TBL] [Abstract][Full Text] [Related]
13. A Modified Model for Assessment for Retreatment with Transarterial Chemoembolization in Chinese Hepatocellular Carcinoma Patients.
Chen L; Ni CF; Chen SX; Cao JM; Zhu HD; Guo JH; Zhu GY; Zhong BY; Ding W; He SC; Deng G; Teng GJ
J Vasc Interv Radiol; 2016 Sep; 27(9):1288-1297. PubMed ID: 27013402
[TBL] [Abstract][Full Text] [Related]
14. Transarterial chemoembolization for hepatocellular carcinoma: development and external validation of the Munich-TACE score.
Op den Winkel M; Nagel D; Op den Winkel P; Trojan J; Paprottka PM; Steib CJ; Schmidt L; Göller M; Stieber P; Göhring P; Herbst A; Rentsch M; De Toni EN; Göke B; Gerbes AL; Kolligs FT
Eur J Gastroenterol Hepatol; 2018 Jan; 30(1):44-53. PubMed ID: 29076939
[TBL] [Abstract][Full Text] [Related]
15. Validation of prognostic accuracy of MESH, HKLC, and BCLC classifications in a large German cohort of hepatocellular carcinoma patients.
Heinrich S; Sprinzl M; Schmidtmann I; Heil E; Koch S; Czauderna C; Heinrich B; Philippe P Diggs L; Wörns MA; Kloeckner R; Galle PR; Marquardt JU; Weinmann A
United European Gastroenterol J; 2020 May; 8(4):444-452. PubMed ID: 32213028
[TBL] [Abstract][Full Text] [Related]
16. Prognostic nomogram for patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization.
Xu L; Peng ZW; Chen MS; Shi M; Zhang YJ; Guo RP; Lin XJ; Lau WY
J Hepatol; 2015 Jul; 63(1):122-30. PubMed ID: 25725438
[TBL] [Abstract][Full Text] [Related]
17. Comparison of combination therapies in the management of hepatocellular carcinoma: transarterial chemoembolization with radiofrequency ablation versus microwave ablation.
Ginsburg M; Zivin SP; Wroblewski K; Doshi T; Vasnani RJ; Van Ha TG
J Vasc Interv Radiol; 2015 Mar; 26(3):330-41. PubMed ID: 25534635
[TBL] [Abstract][Full Text] [Related]
18. Transarterial chemoembolization combined with recombinant human adenovirus type 5 H101 prolongs overall survival of patients with intermediate to advanced hepatocellular carcinoma: a prognostic nomogram study.
He CB; Lao XM; Lin XJ
Chin J Cancer; 2017 Jul; 36(1):59. PubMed ID: 28728568
[TBL] [Abstract][Full Text] [Related]
19. NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging.
Su TH; Liao SH; Hong CM; Liu CJ; Tseng TC; Liu CH; Yang HC; Chen PJ; Chen DS; Chen CL; Adhoute X; Bourlière M; Kao JH
J Gastroenterol Hepatol; 2019 Dec; 34(12):2179-2186. PubMed ID: 31062879
[TBL] [Abstract][Full Text] [Related]
20. Prognostic nomogram for post-surgical treatment with adjuvant TACE in hepatitis B virus-related hepatocellular carcinoma.
Hu H; Han XK; Long XR; Fan J; Yan ZP; Wang JH; Liu R
Oncotarget; 2016 Sep; 7(36):58302-58314. PubMed ID: 27506942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
